|Articles|June 1, 2013

Reportcard: State transparency

Report Card on State Transparency Laws

Based on varying levels of price information and public access to information

 

Alabama         F

Alaska             F

Arizona           F

Arkansas        D

California       D

Colorado         B

Connecticut    F

Delaware        F

Florida            D

Georgia           F

Hawaii             F

Idaho               F

Illinois             C

Indiana           F

Iowa               C

Kansas            F

Kentucky        C

Louisiana        D

Maine             B

Maryland       F

Mass.            A

Michigan        F

Minnesota      B

Mississippi     F

Missouri         F

Montana         F

Nebraska        F

Nevada           C

N.H.                A

New Jersey     F

New Mexico   F

New York       F

N.C.               F

N.D.               F

Ohio              D

Oklahoma       F

Oregon           F

Pa.                 F

R.I.                F

S.C.               F

S.D.              C

Tennessee     F

Texas           D

Utah            C

Vermont      C

Virginia          B

Washington   F

W.V.              D

Wisconsin      B

Wyoming       F

 

Source: Catalyst For Payment Reform, “Report Card on State Price Transparency Laws,” March 18, 2013


Related to this article

Pooja Roy, M.D., on Precedex-induced fever | CHEST 2026
Pooja Roy, M.D., of Houston Methodist Hospital, discusses how Precedex (dexmedetomidine), an ICU sedative, sometimes triggers noninfectious fever, sparking costly sepsis workups, and the need for a test could help clinicians identify the drug as a cause of fever in ICUs.
Eric K. Singhi, M.D., on lung cancer among younger adults
Young-onset lung cancer often strikes nonsmokers, and current screening based on smoking is not likely to find it, says Singhi, an assistant professor at UT MD Anderson Cancer Center in Houston. New risk-based screening, liquid biopsies, and breath tests aim earlier detection.